Health Care & Life Sciences » Pharmaceuticals » Biotechnology industry | Biogen top products based on revenue 2015-2017

Biogen's top products based on revenue 2015-2017

Biogen's top products from 2015 to 2017, based on revenue (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data illustrates Biogen's top products from 2015 to 2017, based on revenue. Biogen Inc. is a Massachusetts-based biotech company specializing in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, the company's top product Tecfidera generated revenues of around 4.2 billion USD.

Tecfidera 3638.4 3968.1 4214
Interferon (incl. Avonex and Plegridy) 2968.7 2795.2 2645.8
Tysabri 1886.1 1963.8 1973.1
Spinraza 4.6 883.7
Benepali 100.6 370.8
Fampyra 89.7 84.9 91.6
Zinbryta 7.8 52.7
Eloctate 319.7 513.2 48.4
Fumaderm 51.4 45.9 39.6
Alprolix 234.5 333.7 26